The importance of body composition assessment for patients with advanced hepatocellular carcinoma by bioelectrical impedance analysis in lenvatinib treatment.
Kenji YamaokaKenichiro KodamaTomokazu KawaokaMasanari KosakaYusuke JohiraYuki ShiraneRyoichi MiuraShigeki YanoSerami MurakamiKei AmiokaKensuke NarutoYuwa AndoYumi KosakaShinsuke UchikawaKazuaki ChayamaHatsue FujinoTakashi NakaharaEisuke MurakamiWataru OkamotoMasami YamauchiDaiki MikiMichio ImamuraShoichi TakahashiAkiko NagaoKazuaki ChayamaHiroshi AikataPublished in: PloS one (2022)
Body composition assessment by BIA before and after lenvatinib treatment is useful in predicting prognosis in lenvatinib-treated patients with HCC.